# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA895029 | B | Binding affinity to Pseudomonas aeruginosa heme oxygenase | Pseudomonas aeruginosa | 8 | ALA1148707 | single protein format | Scientific Literature | |
2. | ALA895030 | B | Binding affinity to Neisseria meningitidis heme oxygenase | Neisseria meningitidis | 8 | ALA1148707 | assay format | Scientific Literature | |
3. | ALA895031 | B | Inhibition of Neisseria meningitidis heme oxygenase-mediated biliveridin production in Escherichia coli BL21 at 1500 uM | Neisseria meningitidis | 8 | ALA1148707 | assay format | Scientific Literature | |
4. | ALA895028 | F | Growth inhibition of Pseudomonas aeruginosa MPA01 at >250 uM | Pseudomonas aeruginosa | 2 | ALA1148707 | organism-based format | Scientific Literature | |
5. | ALA895032 | F | Growth inhibition of Pseudomonas aeruginosa MPA01 at <250 uM | Pseudomonas aeruginosa | 8 | ALA1148707 | organism-based format | Scientific Literature | |
6. | ALA895033 | F | Growth inhibition of Pseudomonas aeruginosa MPA01 in presence of haemoglobin | Pseudomonas aeruginosa | 2 | ALA1148707 | organism-based format | Scientific Literature | |
7. | ALA2345608 | F | Antimicrobial activity against Pseudomonas aeruginosa PAO1 infected in Caenorhabditis elegans glp-4(bn2) assessed as increase in host lifespan at 250 ug/ml | Pseudomonas aeruginosa | 2 | ALA2331541 | organism-based format | Scientific Literature | |
8. | ALA2345609 | B | Binding affinity to Pseudomonas aeruginosa apo Heme oxygenase expressed in Escherichia coli BL21(DE3) assessed as shift in specific resonance at 4.2 mM after 2 hrs by chemical shift NMR analysis | Pseudomonas aeruginosa | 2 | ALA2331541 | assay format | Scientific Literature | |
9. | ALA2345610 | B | Binding affinity to Pseudomonas aeruginosa apo Heme oxygenase expressed in Escherichia coli BL21(DE3) after 4 hrs by STD-NMR analysis | Pseudomonas aeruginosa | 2 | ALA2331541 | assay format | Scientific Literature | |
10. | ALA2345612 | F | Antimicrobial activity against Pseudomonas aeruginosa FRD1 | Pseudomonas aeruginosa | 3 | ALA2331541 | organism-based format | Scientific Literature | |
11. | ALA2345613 | F | Antimicrobial activity against Pseudomonas aeruginosa WR5 | Pseudomonas aeruginosa | 3 | ALA2331541 | organism-based format | Scientific Literature | |
12. | ALA2343229 | F | Antimicrobial activity against Pseudomonas aeruginosa PAO1 | Pseudomonas aeruginosa | 3 | ALA2331541 | organism-based format | Scientific Literature | |
13. | ALA2343230 | B | Binding affinity to Pseudomonas aeruginosa apo Heme oxygenase expressed in Escherichia coli BL21(DE3) assessed as decrease in tryptophan fluorescence | Pseudomonas aeruginosa | 3 | ALA2331541 | assay format | Scientific Literature | |
14. | ALA3881261 | P | Lipophilicity, log P of the compound | 152 | ALA3880431 | small-molecule physicochemical format | Patent Bioactivity Data | ||
15. | ALA3881262 | B | Binding affinity to Neisseria meningitidis wild type apo heme oxygenase expressed in Escherichia coli BL21(DE3) pLysS by spectrofluorimetric analysis | Neisseria meningitidis | 89 | ALA3880431 | assay format | Patent Bioactivity Data | |
16. | ALA3881263 | B | Binding affinity to Pseudomonas aeruginosa MPAO1 wild type apo heme oxygenase by spectrofluorimetric analysis | Pseudomonas aeruginosa | 89 | ALA3880431 | single protein format | Patent Bioactivity Data | |
17. | ALA3881264 | B | Binding affinity to Pseudomonas aeruginosa MPAO1 wild type apo heme oxygenase by NMR analysis | Pseudomonas aeruginosa | 79 | ALA3880431 | single protein format | Patent Bioactivity Data | |
18. | ALA3881265 | B | Inhibition of Neisseria meningitidis heme oxygenase expressed in Escherichia coli BL21(DE3) cells assessed as decrease in alpha-biliverdin production at 1500 uM after 16 hrs by HPLC analysis | Neisseria meningitidis | 31 | ALA3880431 | cell-based format | Patent Bioactivity Data | |
19. | ALA3881278 | F | Antimicrobial activity against Pseudomonas aeruginosa MPAO1 infected in Caenorhabditis elegans assessed as prolongation of survival of infected worms | Pseudomonas aeruginosa | 3 | ALA3880431 | assay format | Patent Bioactivity Data | |
20. | ALA3881279 | F | Antimicrobial activity against Pseudomonas aeruginosa MPAO1 after 10 hrs | Pseudomonas aeruginosa | 87 | ALA3880431 | assay format | Patent Bioactivity Data |